Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Deborah Schiff"'
Autor:
Maya Eylon, Snehit Prabhu, Samuel John, Maxwell J. M. King, Dhruv Bhatt, Kevin J. Curran, Courtney Erickson, Nicole A. Karras, Christine L. Phillips, Prakash Satwani, Michelle Hermiston, Erica Southworth, Susanne H. C. Baumeister, Julie-An Talano, Margaret L. MacMillan, Jenna Rossoff, Challice L. Bonifant, Gary Doug Myers, Rayne H. Rouce, Keri Toner, Timothy A. Driscoll, Emmanuel Katsanis, Dana B. Salzberg, Deborah Schiff, Satiro N. De Oliveira, Christian M. Capitini, Holly L. Pacenta, Thomas Pfeiffer, Niketa C. Shah, Van Huynh, Jodi L. Skiles, Ellen Fraint, Kevin O. McNerney, Troy C. Quigg, Joerg Krueger, John A. Ligon, Vanessa A. Fabrizio, Christina Baggott, Theodore W. Laetsch, Liora M. Schultz
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionMediport use as a clinical option for the administration of chimeric antigen receptor T cell (CAR T cell) therapy in patients with B-cell malignancies has yet to be standardized. Concern for mediport dislodgement, cell infiltration, and i
Externí odkaz:
https://doaj.org/article/63c1f7316ab94ecab4e03921e246dcfd
Autor:
Troy Yi, Jeffrey Steinberg, Scott Olson, Howaida El‐Said, Jun Mo, Eric Anderson, Nicholas Gloude, Deborah Schiff
Publikováno v:
Clinical Case Reports, Vol 11, Iss 6, Pp n/a-n/a (2023)
Key Clinical Message Hydroa vacciniforme‐like lymphoproliferative disorder (HV‐LPD) is a rare cutaneous form of chronic active Epstein–Barr virus (CAEBV) that presents with vesicular lesions induced by sun‐exposure. Arterial aneurysm is a rar
Externí odkaz:
https://doaj.org/article/90d98b76f4a34ba0ab16e2980ce04a95
Autor:
Rosa Nguyen, Huiyun Wu, Stanley Pounds, Hiroto Inaba, Raul C. Ribeiro, David Cullins, Barbara Rooney, Teresa Bell, Norman J. Lacayo, Kenneth Heym, Barbara Degar, Deborah Schiff, William E. Janssen, Brandon Triplett, Ching-Hon Pui, Wing Leung, Jeffrey E. Rubnitz
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-7 (2019)
Abstract Consolidation therapies for children with intermediate- or high-risk acute myeloid leukemia (AML) are urgently needed to achieve higher cure rates while limiting therapy-related toxicities. We determined if adoptive transfer of natural kille
Externí odkaz:
https://doaj.org/article/4196b54e9163489ba534ba9dc6b66a38
Autor:
Leon Chen, Shahidul Islam, David Buchbinder, Ashley V Geerlinks, Hannah L Elfassy, Christiane Querfeld, Jeffrey I. Cohen, Blachy J. Dávila Saldaña, Deborah Schiff, Helen E. Heslop, William Owen, Weni Chang, Martha Pacheco, Evan Shereck, Michael B. Jordan, Nameeta Richard, Catherine M. Bollard, David Hagin, Niraj C. Patel, Shanmuganathan Chandrakasan, Tami D John, Sharat Chandra, Holly K. Miller, Rakesh K. Goyal, Roger Giller, Troy C. Quigg, Elizabeth Stenger, Kanwaldeep K. Mallhi, Challice L. Bonifant
Publikováno v:
Blood Advances
Blood advances, vol 6, iss 2
Blood advances, vol 6, iss 2
Key Points Stem cell transplant improves long-term survival in T/NK CAEBV, though mortality remains high.Development of T/NK lymphoma showed a trend with increased mortality.
Visual Abstract
Chronic active Epstein-Barr virus (EBV) disease (
Visual Abstract
Chronic active Epstein-Barr virus (EBV) disease (
Autor:
Elissa R. Engel, Adrienne Hammill, Denise Adams, Roderic J. Phillips, Michael Jeng, Megha M. Tollefson, Ionela Iacobas, Deborah Schiff, Shoshana Greenberger, Michael Kelly, Ilona Frieden, Nibal Zaghloul, Beth Drolet, Amy Geddis, Dov Goldenberg, Kiersten Ricci
Publikováno v:
Pediatric Blood & Cancer. 70
Autor:
Kevin O. McNerney, Amy Moskop, Lena E. Winestone, Julie Talano, Deborah Schiff, Michael R. Verneris, Theodore W Laetsch, Liora Michal Schultz
Publikováno v:
Transplantation and Cellular Therapy. 29:S205-S206
Autor:
Troy Yi, Jeffrey Steinberg, Scott Olson, Howaida El-Said, Jun Mo, Eric Anderson, Nicholas Gloude, Deborah Schiff
Hydroa vacciniforme-like lymphoproliferative disorder (HV-LPD) is a rare cutaneous form of Chronic active Epstein-Barr virus (CAEBV) that presents with vesicular lesions induced by sun-exposure. We describe a patient with CAEBV and HV-LPD whose cours
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f0ebb59296527f1a70350b45904360e
https://doi.org/10.22541/au.166011139.98788729/v1
https://doi.org/10.22541/au.166011139.98788729/v1
Autor:
Ms. Zahra Hudda, Nicholas J. Gloude, Adam Lane, Deborah Schiff, Eric Anderson, Parinda A. Mehta, Stella M. Davies, Kasiani Myers
Publikováno v:
Transplantation and Cellular Therapy. 29:S269
Autor:
Jeffrey W. Taub, Susana C. Raimondi, Deborah Schiff, Lei Wang, Jeffery Klco, Jeffrey E. Rubnitz, Kenneth Heym, Barbara A. Degar, Ching-Hon Pui, Elaine Coustan-Smith, Allen Eng Juh Yeoh, Hiroto Inaba, Norman J. Lacayo, John K. Choi, Brandon M. Triplett, Raul C. Ribeiro, Stanley Pounds, Jennifer L. McNeer
Publikováno v:
Journal of Clinical Oncology. 37:2072-2081
PURPOSE To identify effective and less toxic therapy for children with acute myeloid leukemia, we introduced clofarabine into the first course of remission induction to reduce exposure to daunorubicin and etoposide. PATIENTS AND METHODS From 2008 thr
Publikováno v:
JNCI: Journal of the National Cancer Institute. 111:719-726
BackgroundChimeric antigen receptor T-cell (CAR-T) therapy is a promising new class of cancer therapy but has a high up-front cost. We evaluated the cost-effectiveness of CAR-T therapy among pediatric patients with relapsed/refractory B-cell acute ly